A Phase 1a Study of PMN310 In Healthy Volunteers

NCT06105528 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: PMN310
DRUG: Placebo

Sponsor

ProMis Neurosciences, Inc